DRUG AND COSMETIC ACT -
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
objective, definition, IAEC, CPCSEA guidelines for breeding & stocking of animals, transfer of acquisition of animals for expt., power to suspect or revoke registration, offences & penalties.
objective, definition, IAEC, CPCSEA guidelines for breeding & stocking of animals, transfer of acquisition of animals for expt., power to suspect or revoke registration, offences & penalties.
Drug Technical Advisory Board- The Central Government constituted this Board, so as to advise the Central Government and the State Governments on technical matters arising out the administration of this Act and to carry out the other functions assigned to it by this Act.
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
This ppt is based on the Animals Act -1960 proposed for the welfare of ANIMALS. It contains the objective and comeetee which were established for the development of animals
The Prevention of Cruelty to Animals Act, 1960, authored by acclaimed dancer and animal lover, Rukmini Devi Arundale, is an Act of the Parliament of India enacted in 1960 to prevent the infliction of unnecessary pain or suffering on animals and to amend the laws relating to the prevention of cruelty to animals.
The prevention of cruelty to animals act 1960Shaik Rasheed
This presentation give the complete information regarding the The Prevention of Cruelty to Animals Act 1960 including the definitions, composition of IAEC, Breeding and stocking of animals, experiments, offences and penalties.
National pharmaceutical pricing authority with drugs price control order (dpc...Tushar Morankar
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified
strengths and dosages under NLEM 2011.
Main Features of the DPCO 2013
• The new order will bring 348 drugs & their 652 formulations under price control.
• The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more.
The prevention of cruelty to animals act, 1960Ravikumar Patil
In that slides providing knowledge about the animal cruelty act, 1960 for the basic knowledge to the pharmacy students regarding subject Pharmaceutical Jurisprudence.
Drug Technical Advisory Board- The Central Government constituted this Board, so as to advise the Central Government and the State Governments on technical matters arising out the administration of this Act and to carry out the other functions assigned to it by this Act.
This act gives an idea about the constitution and functions of PCI. Brief about Education Regulation in India. Registration procedure for the pharmacist in India.
This ppt is based on the Animals Act -1960 proposed for the welfare of ANIMALS. It contains the objective and comeetee which were established for the development of animals
The Prevention of Cruelty to Animals Act, 1960, authored by acclaimed dancer and animal lover, Rukmini Devi Arundale, is an Act of the Parliament of India enacted in 1960 to prevent the infliction of unnecessary pain or suffering on animals and to amend the laws relating to the prevention of cruelty to animals.
The prevention of cruelty to animals act 1960Shaik Rasheed
This presentation give the complete information regarding the The Prevention of Cruelty to Animals Act 1960 including the definitions, composition of IAEC, Breeding and stocking of animals, experiments, offences and penalties.
National pharmaceutical pricing authority with drugs price control order (dpc...Tushar Morankar
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified
strengths and dosages under NLEM 2011.
Main Features of the DPCO 2013
• The new order will bring 348 drugs & their 652 formulations under price control.
• The new policy uses a market-based pricing mechanism against the earlier proposed cost-plus method. The ceiling price would be calculated by taking the simple average of prices of all brands of a drug with a market share of 1% or more.
The prevention of cruelty to animals act, 1960Ravikumar Patil
In that slides providing knowledge about the animal cruelty act, 1960 for the basic knowledge to the pharmacy students regarding subject Pharmaceutical Jurisprudence.
These presentation contains rules and regulation regarding import of drugs. These presentation is the part of series Drug & Cosmetics Act and will be followed by other parts.
5th B.Pharm Pharmaceutical Jurisprudence
Import of Drugs: Classes of drugs and cosmetics prohibited from import, import license and registration certificate, import under license or permit, Offenses and Penalties
Import of drugs - Drugs and cosmetic Act 1940 and rules 1945Swarna kumari S
Drugs and cosmetic Act 1940 and rules 1945. How drugs can be imported. Licensing procedure in India. Prohibited drugs for Import. classes of drugs allowed to import.
The application for Registration and import can be made to the Licensing Authority under the Act i.e. to the Drugs Controller General at CDSCO. Drug and Cosmetic Act 1945: It Contains provisions for classification of drugs under given schedules. Guidelines for the storage,sale,display and prescription of each schedule.
The application for Registration and import can be made to the Licensing Authority under the Act i.e. to the Drugs Controller General at CDSCO. Drug and Cosmetic Act 1945: It Contains provisions for classification of drugs under given schedules. Guidelines for the storage,sale,display and prescription of each schedule.
The application for Registration and import can be made to the Licensing Authority under the Act i.e. to the Drugs Controller General at CDSCO. Drug and Cosmetic Act 1945: It Contains provisions for classification of drugs under given schedules. Guidelines for the storage,sale,display and prescription of each schedule.
Drugs and Cosmetics Act 1940, 1945 Unit-I as per B. Pharm Pharmaceutical Juri...Sagarpamu123
This PPT covers the B. Pharm, Pharmaceutical Jurisprudence Unit-I topics with Objectives, Definitions, Legal definitions of schedules to the Act and
Rules
Import of drugs – Classes of drugs and cosmetics prohibited from import, Import under
license or permit. Offences and penalties.
Manufacture of drugs – Prohibition of manufacture and sale of certain drugs,
Conditions for grant of license and conditions of license for manufacture of drugs,
Manufacture of drugs for test, examination and analysis, manufacture of new drug, loan
license and repacking license.
Pristyn Research Pvt Ltd is a contract research organization specialize in providing tailored clinical research and pharmaceutical development solutions to both the inventor and pharmaceutical industries. With a legacy of years of excellence, we have consistently empowered global enterprises to elevate their regulatory and clinical research endeavours, delivering impactful and high-quality data. Pristyn Research is a professional and reliable name in the pharmaceutical and research industry. We strive to produce validated medical data for research & dedicated professionals.
Our comprehensive suite of services extends beyond clinical trials and operational support. We are your one-stop destination, offering medical writing, regulatory guidance, and scientific research services. We provide a complete package, spanning the journey from drug discovery to regulatory approval, including crucial tech transfer processes. Our impressive track record boasts numerous successfully completed clinical studies and research projects, encompassing vital areas such as medical device testing. We've been instrumental in helping numerous sponsors navigate the complexities of regulatory approvals, ensuring their innovations reach the market.
Pristyn Research is a legally established corporation under the laws of India and proudly bears the registered trademark "Pristyn Research®." Notably, we have recently integrated the esteemed "Pristyn Research Solutions," a renowned leader in corporate training for research and development. Our international affiliations and regional government approvals for training programs underscore our commitment to excellence in education and development. Our vast network of representatives and affiliates spans across various sectors, including corporate, public, private organizations, and professional bodies. This expansive reach reflects our dedication to fostering collaboration and innovation within the clinical research and development domain. In summary, Pristyn is your trusted ally on the journey of scientific discovery and innovation. With a rich history of accomplishments and a forward-looking approach, we are poised to continue making significant contributions to the world of research and pharmaceuticals, consistently raising the bar for excellence.
COMMON REGULATORY AFFAIRS JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated in 2022!Pristyn Research Solutions
COMMON REGULATORY AFFAIRS
JOB INTERVIEW QUESTIONS WITH
ANSWERS By Pristyn Research-Updated 2022.
A quick Job interview short guide For Pharma and all
Life science jobseekers.
info.pristynresearch.com
www.pristynresearch.com
9028839789 | 8999717656
All Medical | Biotech |Micro |B.Sc., M.Sc.
PAN India DRA companies
list alphabetically
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...Pristyn Research Solutions
Quick Job interview short guide For Pharma and all Life science jobseekers.All Medical | Biotech |Micro |B.Sc., M.Sc.
These are the commonly asked questions with their answers asked in job interviews. The file was updated in 2022.
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4, Opposite To Expert Global, Garware Stadium Road, Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 9028839789
Sample Questions are:
What is Pharmacovigilance (PV)?
What are the objectives of PV?
What is MedDRA?
WHAT ARE THE Role of Drug Safety
Associate?
What should narratives consist of?
What are Data assessments in PV?
Which products are covered by PV?
Methods of signal detection?
Why PV is required after clinical
trial?
What is an Adverse Drug Event (ADE)?
What
is the minimum criterion required
for a valid case according to WHO?
When
do you consider an event to be
serious?
What do you mean by causality?
Types of
Unsolicited reports
Sources of Solicited Reports
Name the core regulatory bodies
What is Volume 9A
What do you know
about E2a, E2b and E2c guidelines?
When do you consider a case to be medically confirmed?
What is CemFlow?
What is the yellow card in PV?
What are Comorbid conditions?
What is a medication error?
What is a signal?
Rechallenge
Dechallenge
What are WHO ART, WHO DD and MedDRA and the difference between them?
What is SUSAR?
Adverse Drug Reaction (ADR)
Effectiveness/risk
harm
Essential medicines
Frequency of ADRs
Individual Case Safety Report
ADR Reporting process in PV
VigiFlow
VigiMed
ABBOTTS
COGNIZANT
I 3 GLOBAL DRUG
SAFETY
LAURUS LABS
PARAXEL
SRISTEK
ACCENTURE
CREST.
I GATE PATNI
COMPUTERS
MAHINDRA
SATYAMBSG
PIRAMAL
SUN
PHARMA
ALEMBIC
DIAGNOSEAR
CH
ICON
MAKROCARE
PPD
SYMOGEN
APC PHARMA.
DR REDDY’S
iMEDGlobal,
MANKIND
QUANTUM
SOLUTIONS
SYNOGEN
APCER
ECRON
ACUNOVA
IMS HEALTH
MEDHIMALAYAS
QUINTILES
TAKE
SOLUTIONS
APCER
EMCURE
INC RESEARCH
MEDPACE.
SCIFORMIX
RATIOPHARM
TCS
ASTRAZENECA
FDC
Infocorp
Soft
Solutions
MICRO LABS
RX MD
THOMSON
REUTERS
AUROBINDO
FORTIS
HEALTH CARE
INVENTIVE
MSD (MERCK)
SANTHA
BIOTECH
USV
LIMITED
BESTOCHEM
G7 INFOTECH
IPCA
LABORATORIES
NEKTAR
THERAPEUTICS
SCIFORMIX.
VIMTA LABS
BIOCAD
GENPACT
IPLEX
NORWICH
CLINICAL SERVICES
SHANTHA
BIOTECHNICS
WIPRO
BIOCON
GRANULES
JUBILIANT
BIOSYS NOVARTIS
SIRO
CLINPHARM
WNS
BIOLOGICAL E.
LTD
GVK
KINAPSE
NOVO NORDISK
SP softtech
WOCKHARD
T
BLUEFISH
HCL
LAMBDA
OMNICARECLINICA
L RESEARCH
SRI KRISHNA
PHARMA
4C
Pharma
Solutions
These are the commonly asked questions with their answers asked in any job interviews. The file is updated in 2022.
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4, Opposite To Expert Global, Garware Stadium Road, Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 09607709586
Sample Questions are:
Tell me about yourself?
What are your Career Goals?
Why have you been unemployed for such a long time?
Are you a team player?
Describe your management
style?
What irritates you about co
workers?
What position do you prefer
while in a team working for
project?
Do you consider yourself
successful?
what are your strengths?
what are your weaknesses?
why you left your previous job?
why we should hire you?
are you a complete fresher?
Tell me about your ability to work under pressure?
How long would you expect to work for us if hired?
What are your expectations from a job?
How do you see yourself 5 years from now?
What are your Salary Requirements?
What will you do if we reject you?
DO you have any questions for Us?
Answer it like: If selected: Yes I do, when can I join?
If rejected: Yes I do, rejection is an
opportunity to learn. I will request
you to kindly tell me the reason why I am being rejected today? I will work on my shortcomings and may one day be a part of your
organization.
What is scientific research writing?
Answer: It is the technical writing that scientists do to communicate their research to others [1].
What is a research manuscript?
Answer: A systematic inquiry document that entails collection of data; documentation of critical information; and analysis and interpretation of that data/information, in accordance with suitable methodologies set by specific professional fields and academic disciplines [2].
What is a review article?
Answer: A literature review article is a comprehensive summary of previous research on a topic. It is assumed that by mentioning a previous work in the field of study, that the author has read, evaluated, and assimiliated that work into the work at hand [3].
What is peer review paper?
The peer review paper is a validation of academic work, helps to improve the quality of published research, and increases networking possibilities within research communities [4].
What is meta-analysis?
Answer: A subset of systematic reviews; a method for systematically combining pertinent qualitative and quantitative study data from several selected studies to develop a single conclusion that has greater statistical power [5].
What dissertation?
Answer: A thesis is a hypothesis or conjecture. A PhD dissertation is a lengthy, formal document that argues in defense of a particular thesis. Two important adjectives used to describe a dissertation are ``original'' and ``substantial.'' The scientific method means starting with a hypothesis and then collecting evidence to support or deny it [6].
What are journals?
Answer: A research journal is a periodical that contains articles written by experts in a particular field of study who report the results of research in that field [7].
What does publisher mean?
Answer: Authors and publishers will generally have a publishing agreement (sometimes referred to as an author or licence agreement) in place when a work is published [8].
What is ISSN number?
Answer: An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic [9].
What is volume of a journal?
jobs
INTERVIEW
SOFTSKILLS
BODY LANGUAGE
EYE CONTACT
POSITIVE ATTITUDE
SITTING POSTURE
SMILE
SELF CONFIDENCE
PUBLIC SPEAKING
GOOD DECISION
TIME MANAGEMENT
PUNCTUALITY
PROFESSIONALISM
RESPECT
RESPONSIBILITY
SKIN & BODY CARE
Make-up Hygiene
jobs
INTERVIEW
SOFTSKILLS
BODY LANGUAGE
EYE CONTACT
POSITIVE ATTITUDE
SITTING POSTURE
SMILE
SELF CONFIDENCE
PUBLIC SPEAKING
GOOD DECISION
TIME MANAGEMENT
PUNCTUALITY
PROFESSIONALISM
RESPECT
RESPONSIBILITY
SKIN & BODY CARE
Make-up Hygiene
SYNTHESIS, CHARACTERIZATION, AND STUDY OF ELECTRICAL
CONDUCTIVITY AND THERMOGRAVIMETRIC ANALYSIS OF
CONDUCTING POLYMER COMPOSITES WITH FLY ASH
- A Ph.D. PRE SUBMISSION SEMINAR-
Communication and Soft Skills in Pharma industry are most important to fill the vacuum created due to lack of facilities and guidance during the degree course. To prove the power of personality, Professionalism, Sovereignty, and Excellence in all walks of life for yourself and thus strengthen the shining future of your career and our Country.
NEW DRUG DEVELOPMENT
WHAT DOES DRUG MEAN?
TRADITIONAL SYSTEM OF MEDICINES
NEW DRUG DEVELOPMENT PROCESS
PHASES OF CLINICAL RESEARCH
OVERVIEW OF EACH PHASE
PHASE-0
PHASE-1
PHASE-2
PHASE-3
PHASE-4
CONSIDERATION BEFORE STARTING CLINICAL RESEARCH
AIMS AND OBJECTIVES OF EACH PHASES
.
.
.
FOR MORE RELATED QUERIES CONTACT US ON- 9028839789
FOR ENROLLMENT IN NEXT BATCH CONTACT ON ABOVE MENTIONED NUMBER
https://www.youtube.com/watch?time_continue=4&v=F4jiJD0O8T8
NEW DRUG DEVELOPMENT
Clinical Research - Phases
New Drug Development Process
CONTENT OF INDA
CONTENT OF NDA
.
.
.
FOR MORE RELATED QUERIES CONTACT US ON 09028839789
FOR ENROLLMENT IN NEXT BATCH KINDLY CONTACT US ON THE ABOVE MENTIONED CONTACT NUMBER
http://pristynresearch.com/
ETHICS COMMITTEE
MEMBERS OF ETHICS COMMITTEE
SOME ETHICS COMMITTEE AROUND THE WORLD
What authority does EC/IRB have?
.
.
.
FOR ENROLLMENT CALL US ON - 9028839789
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4 ,Opposite To Expert Global, Garware Stadium Road , Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 09607709586
COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN DRUG REGULATORY AFFAIRS ...Pristyn Research Solutions
THESE ARE SOME COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS ASKED IN DRUG REGULATORY AFFAIRS INTERVIEW
FOR ENROLLMENT CALL US ON - 9028839789
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
FACEBOOK- https://www.facebook.com/pristynsolutions
INSTAGRAM- https://www.instagram.com/pristyn_res...
TWITTER- https://twitter.com/Pristynresearch
SLIDESHARE- https://www.slideshare.net/azherkhan5916
LINKEDIN- https://www.linkedin.com/in/pristyn-research-191072119/
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4 ,Opposite To Expert Global, Garware Stadium Road , Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 09607709586
These are some frequently asked questions in Pharmacovigilance Interview & its Preparation.
"HANDS IN HANDS LEARNING"
FOR ENROLLMENT-
CONTACT US ON-
https://pristynresearch.com/
MAIL ID - pristynresearch@gmail.com
ADDRESS-
1) Parmar Trade Centre, A-wing,105/106, Sadhu Vaswani Chowk, Pune, 411001. Email: info@pristynresearch.com Phone: 09028839789
2)T-21/4 ,Opposite To Expert Global, Garware Stadium Road , Software Technology Park of India(STPI), MIDC, Aurangabad-431001. Email: info@pristynresearch.com Call us: 09607709586
PHARMACOVIGILANCE TERMINOLOGIES ASKED IN INTERVIEWS-
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
DRUG ACTION
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
CLINICAL RESEARCH IS ONE WHICH MADE POSSIBLE , ORAGAN TRANSPLANT, MANAGE OF DIBETIS, ADDED YEAR OF AIDS PATIENT.
HOW WELL NEW APPROCHES AND WORK IN PEOPLE.
THE APPROACHES CAN BE MEDICAL, BEHAVIORAL, OR MANAGEMENT.
EACH STUDY ANSWER SCIENTIFIC QUESTION.
GENERAL INTRODUCTION OF CLINICAL RESEARCH
KEY POINTS AND CONCEPTUAL DEFINATION
DRUG DISCOVERY PROCESS
SOURCES OF DRUG DISCOVERY
PRECLINICAL STUDY
FOR MORE RELATED QUERIES CONTACT US ON- 9028839789
FOR ENROLLMENT IN NEXT BATCH CONTACT ON ABOVE MENTIONED NUMBER
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
1. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
Drugs & cosmetics ACT & RULES (Import of Drugs)
Learning Objectives:
To understand Drugs & Cosmetics Act & Rules
Classes of drugs whose import is prohibited in India
Classes of drugs which may be imported under License or permit
Classes of drugs which may be imported without License or permit
Concept of Misbranded drugs, Adulterated Drugs and Spurious Drugs
Offences & Penalties related to the Import of Drugs
Description:
As we stated in the last module that Drugs & Cosmetics Act & Rules came in force 10th
April,1940
was having controls over operations related to Allopathic drugs only, Later amended to it was
having controls over operations related to Ayurveda, Unani , Siddha and Homeopathic drugs and
cosmetics. This Act kept amended till 2008. This act has various provisions related to Import,
manufacture, Sale, Labeling and Administration. A brief discussion of the Import of drugs and
provisions to it are covered in this chapter of PRISTYN RESEARCH SOLUTIONS.
IMPORT OF DRUGS:
Import of the Drugs, under D & C Act is defined as the process of bringing a material from a place
outside India to a place in India.
2. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
Classification:
1) Classes of drugs who’s 2) Classes of drugs which may 3) Classes of drugs can
Import is prohibited in India be imported under License be imported without License
(Misbranded drugs) (Schedule C & C1 Drugs)
(Schedule X Drugs) Drugs other than
(Adulterated Drugs) (Drugs for Analytical purpose) Specified in Class 1 & 2
(Drugs for Personal use)
(Spurious Drugs) (New Drugs)
1) Classes of drugs whose import is prohibited in India
The following classes of drugs are prohibited to be imported into India.
MISBRANDED DRUGS:
Example:
Drugs colored,coated,powdered or
polished to conceal damaged or to
appear to be or better therapeutic
value than they really are.
Drugs not lebelled in the prescribed
manner
Drugs which are otherwise false and
misleading in claims
These are the drugs which are
prohibited to import in India
by law and if anybody comes
in contravention to the Act
related to the import of
misbranded Drug will be
punishable under the Act.
3. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
ADULTERATED DRUGS:
Drugs consisting of any filthy, putrid or decomposed substances
Drugs containing any harmful or toxic substances which may make them injurious to health
Drugs proceed or stored under insanitary conditions which may make them injurious to health
Drugs packed in container composed of poisonous or deleterious substances.
Drugs having color other than prescribed, and adulterated drugs are also those drugs admixed with
any substance which reduces their quality or strength.
4. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
SPURIOUS DRUGS:
Spurious drugs are those drugs which are imitations or substitute for other drugs
Drugs bears the name of other drug and drugs bear the name of manufacturer which are fictitious
& whose they are not the truly product.
Drugs containing ingredients in such quantities that there is no therapeutic justification
These all are those drugs which are not of standard quality and which do not comply with the
standard prescribed for them under the Act, Hence their import in India is prohibited. However
central Government by notification in official Gazette & in consultation with DTAB permit import of any
above listed class of Drug.
Case Study Related to drugs whose import is prohibited in India:
Indian pharmacologist charged with smuggling fake drugs
http://ibnlive.in.com/news/indian-pharmacologist-charged-with-
smuggling-fake-drugs/498492-2.html
5. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
2) Classes of drugs which may be imported under License:
There are five classes of drugs which can be imported into India after having a valid license or
permit, license is issued by licensing authorities it remains valid up to 31 Dec of the year following
the year in which it was granted, unless suspended or cancelled earlier. Licensing Authorities after
successful inspection grant a license for import of drugs for respective class. In any changes in the
constitutions of a license firm, the licensee should inform the licensing authority accordingly. A
separate license is necessary in respect of import of the drugs from each manufacturer.
A. IMPORT OF SCHEDULE C AND C1 DRUGS:
As stated a license is require for Import of schedule C and C1 drugs, It is granted with subject to
the following conditions:
The licensee must have adequate facilities for the storage of imported drugs so that
the properties of the drugs are preserved.
A record of the sale of imported drugs showing the particulars of the names of the
drugs and of the persons to whom they have been sold should be maintained.
The Licensee must allow the drug Inspector to inspect the premises where
imported drugs are stocked should be allowed, to check the record in respect of
their purchase and sale, and means employed to test the potency of the drug and to
take their samples for check analysis.
Licensee must, on request, furnish to the licensing authority sample of the drugs
from all batches or from such batches as the licensing authority may direct with
detail of the test if any carried out.
Licensee must not sell drugs from any batch from which samples have been
furnished to the licensing authority in case he is so advised by the said authority.
He may however dispatch the batch when a certificate has been issued to him by
licensing authority authorizing him to sell the drug from the batch. In case the
licensee is informed by the licensing authority that drug does not comply with the
prescribed standards. He should recall the batch from the sales as far as possible.
Must comply with the undertaking given in the form 9 and with such further
requirements has may be specified and of which he has been given not less than
four months noticed by licensing authority.
The import license or certain specified drugs, if the licensee or manufacturer fails
to observe any of the conditions of the license, after giving him an opportunity of
explaining himself. Person aggrieved by the decision of the licensing authority
may appeal to a court of law within 3 months of the date of order whose decision
shall be final.
6. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
B. IMPORT OF SCHEDULE X DRUGS:
C.IMPORT OF SMALL QUANTITIES OF DRUGS FOR EXAMINATION, TESTS OR ANALYSIS
Authority duly signed by the head of the institution where
the drug is to be used. The licensing authority has the right to call for such further particular as
may be considered necessary before the issue of the license of the prospective applicant. The
license is issued subject to the following conditions:
a) The licensee must use imported drugs exclusively for the purpose for which they are imported
and at the places specified in the license.
b) The license must keep the record of the substances imported under the license with respect to
their quantities, name of the manufacturer and the dates of their import and have to make report of
the details to the licensing authority.
c) Licensee must comply with such further conditions as may be prescribed and of which he has been given
at least one month’s notice by the licensing authority.
d) If the licensee fails to keep any conditions of the license the same may be cancelled by authority. The
licensee, however, has the right of appeal to the Central government within 3 months of the date of such
cancellation.
A license is necessary for the
import of small quantities of drugs
for analytical purposes. The
application for the license is
required to be made to the
licensing
A license is necessary for the import of schedule X drugs,
before granting the license the licensing authority ensures that
the licensee has proper facilities for storage of drug and may
also enquire into the occupation, trade or business ordinarily
carried out by the applicant.
The licensing authority may also refuse to grant the license if
the license granted previously to the applicant was suspended
or cancelled or in case the applicant fail to comply with any
provisions of the act and rules or has been convicted under a
drug and cosmetic act or narcotic and psychotropic substances
act however a person aggrieved by such decisions may appeal
to the central government within 30days whose decision shall
be final.
7. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
D. IMPORT OF DRUGS FOR PERSONAL USE:
In the normal course small quantities of drugs (up to average 100 doses) whose import is
otherwise prohibited ,may be imported without any permit ,provided they form part of
passenger’s bonafide luggage, are meant for his or her exclusive personal use and are declared
to the custom authorities. (In exceptional circumstances import of the drugs in excess of 100
doses may be sanctioned by the customs authorities).
If the drugs are imported for personal use and otherwise than as a part of passenger’s baggage
a permit is necessary to cover the import. The permit is granted by the licensing authority, if
the authority is satisfied that (a) the drug is for bonafide personal use and (b) the quantity
sought to be imported is reasonable and is covered by a prescription of a Registered Medical
Practitioner.
E. IMPORT OF NEW DRUGS:
No new drugs are allowed to be imported into the country without the sanctioned of the
licensing authority in writing. All drugs whose composition is not recognized as safe for the
use by experts and which have not been used to any large extent or for any appreciable
period of time are to be regarded as new drug.
Permission for the import of new drugs may be obtained from the licensing authority after
furnishing to him documentary evidence of the standards of quality, purity and strength of the
drug. The application for import of new drugs including their fixed dose combinations should
be accompanied as specified in schedule Y, provided that data on clinical trial for a drug may
not be submitted ,if the licensing authority decides to grant import permission without it in
public interest.
3) Classes of drugs which can be imported without License:
Drugs other than dose discussed above, may be imported without any permit or license.
However, before such drugs are imported into the country, their importers or manufacturers
should submit a declaration to the Customs Collector that they comply with all the
provisions of chapter 3 of drug and cosmetics act and the rules made under the same.
8. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
SOME OTHER PROVISIONS REGARDING IMPORT OF DRUGS
A. Custom collector’s authority over import:
The law letting to goods whose import is prohibited
under section 18 of the see customs act 1878 is
applicable to drugs whose import is prohibited. The
customs collector can detain any consignment of
drugs whose import is prohibited and report to the
drugs controller of India. Samples of any drugs
whose standards are suspected or whose compliance
with the act and rules in it doubt can be sent to
central drugs laboratory or any other laboratory
specified for analysis and report.
Consignment from which samples have been drawn
and sent for analysis may be detained by customs
collectors until receipt of reports on analysis.
however ,if the importer gives an undertaking in
writing to not to disposed of drugs from such
consignment without custom collector’s consent and
to return the same to him. If so required with 10 days
of notification the consignment may be released to
the importer.
9. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
If the report of the analysis indicates that the sample of any drug in the consignment does not come
up to the prescribed standards or contravenes any of the provisions of chapter 3rd
of the act and the
rules in any manner and the defects are such that they cannot be remedied by the importer, the
custom collector may ask the importer to export the consignment bag to the manufacturer within 2
months of the receipt of information from the custom collector or forfeit it to the central
government for destruction . If the importer is aggrieved by the report of analysis, he may make
representation against the report to the custom collector who shall forward the samples together
with representation to the licensing authority. The decision of the licensing authority shall be final
in the matter. In case the report of analysis indicated that the contravention is such that it can be
remedied by the importer ,the customs collector may permit the import provided the importer gives
an undertaking not to dispose of the without the permission of the officer authorized in this behalf
by the central government.
B. Place at which Drugs may be imported:
Import of drugs in India is allowed only through the following places:
10. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
Places in India where Drugs can
be imported under D&C Act.
PRISTYN RESEARCH SOLUTIONS
Mumbai
Madras
Calcutta
Cochin
Vishakhapatnam
Delhi
Ahmadabad
Amritsar
Ranaghat
Raxaul
Bongaon
11. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
C. Offences and penalties Related to import of Dugs:
Summary:
In this session of PRISTYN RESEARCH SOLUTIONS we have learnt about the provisions of
Drugs & Cosmetics Act related to the import of any drug into India, where you can now better
explain about the Misbranded, Adulterated and Spurious Drugs. Also about the License and permit
required for import of drugs. Now you have better understanding about the various places & routes
at which drugs are imported. Offences & Penalties related to import of drug should keep in the
mind while dealing with import related activities in India as Drugs & Cosmetics Act has strict
regulations and rules over it.
OFFENCES PENALTIES
Anyone who imports a spurious or
adulterated drug or drugs which involve any
risk to human beings or animals or drugs
not having claimed therapeutic value
Shall be punished with imprisonment up to
3 years or fine up to Rs. 5000 on first
conviction and imprisonment up to 5 years
& fine up to Rs. 10000 for any subsequent
offence
Persons importing drugs in contravention of
other provisions
Punishable with imprisonment up to 6
months and/or fine up to Rs. 500 on first
conviction and imprisonment up to 1 year
&/or fine up to Rs. 1000 for any subsequent
conviction.
These punishments shall be in addition to any punishment that may
be imposed under Sea customs Act. The offence cannot be tried in
courts inferior to that of a Metropolitan Magistrate or Judicial
Magistrate of the First class.
12. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
Note: Other oral description and case studies are detail explained in attached video.
Competitive Exam Possible Practice Questions:
1. Correct the following, if necessary:
I. The drugs may be imported by air at Bombay, Calcutta, Delhi, Madras and Cochin.
II. A drug which claims to cure a disease specified in schedule X cannot be imported.
III. Drugs other than chose in schedule C and C1 and X can be imported without
license.
IV. In the normal course a passenger coming from any foreign country can be bring up
to 500 average doses of a drug meant for his /her/personal use.
V. No drug license is required for quinine and other antimalarial drugs.
VI. By sea, drugs can be imported at Delhi, Calcutta, Bombay, Madras and Cochin.
VII. Drugs can be imported by air at Bombay, Delhi, Madras, Calcutta and Allahabad.
VIII. A patent medicine for cure of diabetes whose true formula is disclosed can be
destroyed.
IX. Consignments of substandard medicine not collected by importers can be destroyed.
2. Explain:
I. How consignment of imported drugs is found to be substandard required to be
disposed off?
II. Whether homeopathic drugs may be imported into India without any license.
3. What types of preparations are exempted from duty?
4. What is underlying reason for:
I. Ban on import of drugs which claim to cure diseases specified in schedule J.
II. Discuss whether a person importing the drug such as (3) insulin, antibiotics, drugs
for appendicitis, cancer, insanity etc. is contravening the law? If yes, how?
III. Why complaints about non-standard drugs cannot be filed in courts directly by
individual citizens.
13. [DRUGS & COSMETICS ACT & RULES (IMPORT OF DRUGS)] www.pristynresearch.com
PRISTYN RESEARCH SOLUTIONS-PUNE & AURANGABAD | Confidential
5. Fill in the blanks:
I. Imported drugs declared to be substandard should be
_________________________ or ____________________________.
II. From Pakistan import of drugs by rail is allowed at
__________________________ or ___________________________.
III. Proprietary drugs _______________________ is not disclosed cannot be imported.
IV. No license is necessary for _______________for __________________ used
solely __________________ of drugs.
V. By sea drugs can be imported at _______________, ________________,
_______________, and __________________.
VI. Patent medicines cannot be imported unless there ________________________ is
given.
VII. No license is needed for import of drugs other than _______________________.